Biofilm Formation in Orthopaedic Infections

Extracellular Polymeric Substance (EPS) Matrix

Composition (by weight):

• Water: 80-90% of biofilm volume
• Polysaccharides: 40-50% of dry weight (structural backbone)
• eDNA (extracellular DNA): 10-20% of dry weight
• Proteins: 20-30% of dry weight (enzymes, adhesins)
• Lipids: 5-10% of dry weight
• Bacterial cells: Only 10-15% of biofilm volume

Polysaccharides:

• PIA (polysaccharide intercellular adhesin): S. epidermidis, encoded by ica genes
• PNAG (poly-N-acetylglucosamine): Staphylococcus species
• Alginate: Pseudomonas aeruginosa
• Pel and Psl: Pseudomonas aeruginosa
• Functions: Structural scaffold, adhesion, protection from desiccation and immune cells

Extracellular DNA (eDNA):

• Released from lysed bacteria or actively secreted
• Provides structural support (scaffolding)
• Binds cationic antibiotics (aminoglycosides, polymyxins) - reduces penetration
• Contains antibiotic resistance genes (horizontal gene transfer within biofilm)
• DNase treatment can disrupt young biofilms (research application)

Proteins:

• Adhesins: Bind to host proteins and implant surfaces
• Enzymes: Beta-lactamases, proteases, nucleases
• Amyloid fibrils: Structural support (Staphylococcus, E. coli)

The EPS matrix is the key protective element of biofilm.

Three-Dimensional Biofilm Architecture

Structural organization:

• Mushroom-like towers: Bacterial aggregates extending into fluid
• Water channels: 10-50 micrometers wide, flow nutrients and waste
• Basal layer: Dense bacterial layer adherent to surface
• Heterogeneous structure: Not uniform - variable density, pH, oxygen

Microenvironments within biofilm:

• Aerobic zones: Outer layers, high oxygen, active growth
• Microaerobic zones: Middle layers, moderate metabolism
• Anaerobic zones: Deep layers, low oxygen, slow growth
• Acidic zones: Bacterial metabolism creates pH gradients (pH 5-7)
• Nutrient-limited zones: Depths where nutrients depleted

Functional significance:

• Water channels allow nutrient flow to deep layers (primitive circulatory system)
• pH gradients affect antibiotic activity (many antibiotics less active at low pH)
• Oxygen gradients create niches for different metabolic states
• Nutrient limitation in depths causes dormancy (persister cells)

3D architecture creates protected microenvironments that promote bacterial survival.

Persister Cells - The Achilles' Heel of Treatment

Definition: Persister cells are phenotypic variants that are dormant, non-growing, and tolerant to all antibiotics despite being genetically identical to susceptible bacteria.

Characteristics:

• Frequency: 0.1-1% of biofilm bacteria
• Metabolic state: Dormant, non-dividing
• Antibiotic tolerance: Resistant to ALL antibiotics (not genetic resistance)
• Reversible: Return to active state when conditions improve
• Location: Deep in biofilm where nutrients limited

Mechanisms of persistence:

• Toxin-antitoxin systems: HipA-HipB, MazE-MazF (induce dormancy)
• Stringent response: (p)ppGpp alarmone slows metabolism
• SOS response: DNA damage response, growth arrest
• Low ATP: Insufficient energy for active transport of antibiotics

Clinical significance:

• Survive antibiotic treatment: Antibiotics target dividing cells, persisters dormant
• Cause relapse: When antibiotics stopped, persisters reactivate and repopulate
• Explain chronic infection: Cycles of suppression (on antibiotics) and relapse (off antibiotics)
• Require physical removal: Cannot be killed by antibiotics - implant removal necessary

Persister cells are the ultimate reason why biofilm infections cannot be cured with antibiotics alone.

Quorum Sensing - Bacterial Communication

Definition: Quorum sensing is cell-cell communication via small diffusible signal molecules (autoinducers) that coordinate group behavior when bacterial density reaches threshold.

Mechanism:

1. Bacteria produce autoinducer molecules (AI)
2. AI concentration increases as bacterial density increases
3. At threshold (quorum), AI binds to receptor
4. Receptor activates gene expression
5. Coordinated behavior: biofilm formation, virulence, dispersal

Autoinducer systems:

• Gram-positive (Staphylococcus): Autoinducing peptides (AIP), accessory gene regulator (agr) system
• Gram-negative (Pseudomonas): Acyl-homoserine lactones (AHL), LasI/LasR, RhlI/RhlR systems
• Universal: AI-2 (used by both gram-positive and gram-negative)

Functions regulated by quorum sensing:

• Biofilm formation: Initiates EPS production when density sufficient
• Virulence factor expression: Toxins, proteases activated at high density
• Dispersal: Triggers biofilm breakup and planktonic spread
• Antibiotic resistance: Induces efflux pumps and resistance mechanisms

Clinical relevance:

• Target for therapy: Quorum sensing inhibitors (QSI) being researched
• Dispersal trigger: Quorum sensing signals can trigger acute exacerbations
• Coordination advantage: Bacteria act as multicellular organism, not individuals

Quorum sensing allows bacteria to coordinate biofilm formation and dispersal.

Biofilm in Prosthetic Joint Infections

Biofilm formation on implants:

• Bacteria attach within hours of contamination (intraoperative or hematogenous)
• Mature biofilm established by 48-72 hours
• Coagulase-negative Staphylococci (S. epidermidis) are master biofilm formers
• Biofilm provides sanctuary from antibiotics and immune cells

Treatment strategies based on biofilm maturity:

Acute infection (less than 3 weeks symptoms, less than 3 months post-op):

• Biofilm not yet mature or well-established
• DAIR (debridement, antibiotics, implant retention) possible
• Success rate: 50-70% if treated early
• Requires aggressive debridement, implant exchange of modular parts, biofilm-active antibiotics (rifampicin)

Chronic infection (greater than 3 weeks symptoms):

• Mature biofilm established
• Implant removal mandatory for cure
• Two-stage exchange: Remove implant + antibiotic spacer, then reimplantation after 6-12 weeks
• Suppressive antibiotics without removal: Temporary symptom control but eventual failure

Biofilm-active antibiotics:

• Rifampicin: Best biofilm penetration, NEVER monotherapy (rapid resistance)
• Fluoroquinolones: Moderate penetration, bactericidal
• Linezolid: Good penetration, oral bioavailability
• Daptomycin: Biofilm activity against Staphylococcus
• Avoid: Vancomycin (poor biofilm penetration despite IV use)

Biofilm in Chronic Osteomyelitis

Biofilm formation on necrotic bone (sequestrum):

• Dead bone (sequestrum) provides surface for biofilm attachment
• Avascular tissue prevents antibiotic and immune cell access
• Biofilm protects bacteria from host defenses
• Explains relapsing nature of chronic osteomyelitis

Treatment principles:

• Debridement of ALL necrotic tissue essential (remove biofilm substrate)
• Sequestrum removal mandatory (cannot be sterilized with antibiotics)
• Viable tissue preservation while excising necrotic bone
• Dead space management: Antibiotic beads, muscle flap, bone graft
• Prolonged antibiotics: 6-12 weeks IV + PO (suppress remaining bacteria)

Why antibiotics alone fail:

• Biofilm on sequestrum impenetrable to antibiotics
• Avascular necrotic tissue has no blood flow (no antibiotic delivery)
• Persister cells in biofilm survive all antibiotic courses
• Relapse when antibiotics stopped (persisters reactivate)

Preventing Biofilm Formation

Perioperative strategies:

1. Antibiotic prophylaxis:

• Given within 60 minutes before incision (optimal: 30 minutes)
• Achieves tissue levels BEFORE bacterial contamination
• Prevents initial attachment (Stage 1 biofilm)
• Cefazolin 2g IV (3g if greater than 120kg) standard for arthroplasty
• Redose if surgery greater than 4 hours or blood loss greater than 1500mL

2. Surgical technique:

• Minimize operative time (less contamination exposure)
• Gentle tissue handling (reduce necrosis, hematoma)
• Copious irrigation (remove bacteria before attachment)
• Wound closure without dead space
• Minimize implant surface area (only what needed)

3. Implant modifications (research/emerging):

• Antibiotic-loaded bone cement: PMMA with gentamicin/vancomycin
• Silver-coated implants: Antimicrobial surface (Ag+ ions toxic to bacteria)
• Chlorhexidine coatings: Prevent bacterial attachment
• Nanotextured surfaces: Too small for bacteria to attach (research)

Patient optimization:

• Glycemic control: HbA1c less than 7.5% (diabetes impairs immunity)
• Smoking cessation: 4-6 weeks preoperative (improves vascularity)
• Weight loss: BMI less than 40 (reduces wound complications)
• Nutritional optimization: Albumin greater than 3.5 g/dL
• MRSA decolonization: Nasal mupirocin + chlorhexidine baths if colonized

Diagnosing Biofilm Infections

Challenges:

• Bacteria in biofilm difficult to culture (dormant, slow-growing)
• Standard culture methods target planktonic bacteria
• Biofilm bacteria may not be released from implant surface
• Culture-negative rate 10-30% in PJI

Improved culture techniques:

Sonication of explanted implants:

• Explanted implant placed in saline
• Ultrasonic waves disrupt biofilm, release bacteria
• Fluid cultured for bacteria
• Increases culture yield by 20-30% compared to tissue samples alone
• Threshold: Greater than 50 CFU/mL = infected (per Trampuz criteria)

Multiple tissue samples:

• 5-7 samples from different sites (MSIS criteria)
• Greater than or equal to 2 positive cultures same organism = infected
• More samples = higher sensitivity for biofilm bacteria

Extended incubation:

• Standard incubation: 5 days
• Extended incubation: 7-14 days for fastidious organisms (Cutibacterium, Kingella, fungi)
• Slow-growing biofilm bacteria require longer to grow in culture

Molecular diagnostics:

• 16S rRNA PCR: Detects bacteria in culture-negative samples
• Next-generation sequencing: Identifies all bacteria present (including unculturable)
• Expensive, not routine, but helpful in culture-negative PJI

Biomarkers:

• Synovial fluid analysis: WBC greater than 3000/μL, PMN greater than 80% suggests infection
• Alpha-defensin: Antimicrobial peptide elevated in PJI (sensitivity 80-97%)
• Leukocyte esterase: Point-of-care test (colorimetric strip)

Sonication and multiple tissue samples are the most practical methods to improve biofilm detection.